Cargando…
Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278329/ https://www.ncbi.nlm.nih.gov/pubmed/32550866 http://dx.doi.org/10.1177/1758835920928636 |
| _version_ | 1783543313674010624 |
|---|---|
| author | Ardalan, Bach |
| author_facet | Ardalan, Bach |
| author_sort | Ardalan, Bach |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7278329 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72783292020-06-17 Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 Ardalan, Bach Ther Adv Med Oncol Letter to the Editor SAGE Publications 2020-06-07 /pmc/articles/PMC7278329/ /pubmed/32550866 http://dx.doi.org/10.1177/1758835920928636 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Ardalan, Bach Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 |
| title | Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 |
| title_full | Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 |
| title_fullStr | Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 |
| title_full_unstemmed | Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 |
| title_short | Letter to the editor: Re: Ratti M, Hahne JC, Toppo L, et al. Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. Ther Adv Med Oncol. 2019 |
| title_sort | letter to the editor: re: ratti m, hahne jc, toppo l, et al. major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data. ther adv med oncol. 2019 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278329/ https://www.ncbi.nlm.nih.gov/pubmed/32550866 http://dx.doi.org/10.1177/1758835920928636 |
| work_keys_str_mv | AT ardalanbach lettertotheeditorrerattimhahnejctoppoletalmajorinnovationsandclinicalapplicationsofdisodiumlevofolinateareviewofavailablepreclinicalandclinicaldatatheradvmedoncol2019 |